Gilead Sciences, Inc.
GILD
$118.37
-$0.65-0.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 49.05% | -26.25% | 42.30% | -22.37% | 138.71% |
| Total Depreciation and Amortization | -0.72% | 0.43% | 0.43% | -0.58% | 0.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -75.61% | 4,768.75% | -99.07% | 206.22% | -90.86% |
| Change in Net Operating Assets | -94.97% | -313.87% | -24.77% | 141.53% | -236.82% |
| Cash from Operations | -52.93% | -40.94% | -30.96% | 225.21% | -40.29% |
| Capital Expenditure | -2.88% | 29.25% | -4.26% | -8.46% | -23.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 92.31% | -264.00% | 86.84% | -275.00% | 96.24% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5,131.58% | -1,166.67% | -400.00% | 104.00% | -101.29% |
| Cash from Investing | -409.88% | -84.44% | 68.31% | -131.27% | 86.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.49% | -25,071.43% | 93.75% | 93.95% | -- |
| Issuance of Common Stock | -89.29% | 45.66% | 76.53% | 1,860.00% | -96.58% |
| Repurchase of Common Stock | 27.81% | -108.57% | -16.67% | -200.00% | 75.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.58% | -3.80% | 1.02% | -1.13% | 1.82% |
| Other Financing Activities | 63.64% | -274.47% | 42.68% | -134.29% | 70.09% |
| Cash from Financing | 54.26% | -251.59% | 263.89% | 53.30% | -116.97% |
| Foreign Exchange rate Adjustments | 284.21% | 134.55% | -225.00% | 500.00% | 38.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.72% | -141.68% | 118.86% | 216.34% | -42.36% |